+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Calcitriol"

From
Moderate Psoriasis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Moderate Psoriasis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Calcitriol is a type of psoriasis drug used to treat moderate to severe plaque psoriasis. It is a synthetic form of vitamin D3, which helps to reduce inflammation and slow the growth of skin cells. Calcitriol is available in both topical and oral forms, and is often used in combination with other psoriasis treatments. It is generally well-tolerated, but can cause side effects such as skin irritation, itching, and redness. The calcitriol market is a growing segment of the psoriasis drug market. It is used to treat a wide range of psoriasis symptoms, from mild to severe. It is also used to treat other skin conditions, such as eczema and acne. As the prevalence of psoriasis increases, the demand for calcitriol is expected to rise. Some companies in the calcitriol market include AbbVie, Amgen, and Novartis. Other companies include Celgene, Janssen, and Sun Pharmaceuticals. Show Less Read more